Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study

This study is designed to learn more about a condition called Chronic Inflammatory Demyelinating Polyradiculoneuropathy, or CIDP for short. CIDP is a rare, long-term condition where your body's immune system mistakenly attacks the protective covering around your nerves. This can lead to muscle weakness, numbness, and tingling, often getting worse over time or coming and going in 'flares'.

The main goal of this particular study is to see how well a new treatment, called efgartigimod, works for people with CIDP in real-world situations. Unlike some studies where patients might be given a specific treatment or a dummy pill, here, doctors will treat their patients with efgartigimod as they usually would, based on what's best for each individual. Researchers will then observe what happens.

They also want to understand the typical care journey for CIDP patients using efgartigimod, from when they start treatment to how they manage their condition over time. This includes looking at how often people need to use healthcare, such as visiting their doctor or specialist, which can help improve care for others in the future. By collecting this information, doctors and researchers hope to get a clearer picture of CIDP and how efgartigimod can help people affected by it.